| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |